Template:Drug List/ja: Difference between revisions
No edit summary |
No edit summary |
||
(11 intermediate revisions by the same user not shown) | |||
Line 45: | Line 45: | ||
| abbr5 = gastrointestinal | | abbr5 = gastrointestinal | ||
| list5 = | | list5 = | ||
{{Navbox|subgroup | |||
|group1=[[Antidiarrheal/ja|止瀉薬]] | |||
|list1=[[Probiotics/ja|プロバイオティクス]] | |||
}} | |||
<!-------------------------------------> | <!-------------------------------------> | ||
Line 92: | Line 96: | ||
|list3=配合薬 | |list3=配合薬 | ||
}} | }} | ||
}} | |||
|group2=[[Lipid-lowering agent/ja|脂質異常症治療薬]] | |||
|list2={{Navbox|child | |||
|group1=スタチン | |||
|list1= | |||
|group2=フィブラート | |||
|list2= | |||
|group3=その他 | |||
|list3= | |||
*EPA製剤 | |||
**[[Omega-3 acid ethyl esters/ja|オメガ3酸エチルエステル]] | |||
**[[Ethyl eicosapentaenoic acid/ja|エイコサペンタエン酸エチル]] | |||
}} | }} | ||
}} | }} | ||
Line 98: | Line 114: | ||
| abbr7 = genitourinary | | abbr7 = genitourinary | ||
| list7 = | | list7 = | ||
{{Navbox|subgroup | |||
|group1=[[Hyperuricemia/ja|高尿酸血症]] | |||
|list1= | |||
* [[Xanthine oxidase inhibitor/ja|キサンチンオキシダーゼ阻害剤]] | |||
* [[Uricosurics/ja|尿酸排泄促進薬]] | |||
}} | |||
<!--------------------------- | <!--------------------------- | ||
Line 181: | Line 203: | ||
|group16=祛湿剤 | |group16=祛湿剤 | ||
|list16= | |list16=* [[真武湯]](30) | ||
|group17=祛痰剤 | |group17=祛痰剤 | ||
Line 202: | Line 224: | ||
}} | }} | ||
<!-------------------------- | <!-------------------------- | ||
| group14 = その他 | | group14 = その他 | ||
| abbr14 = etc | | abbr14 = etc | ||
| list14 = | | list14 = | ||
-----------> | |||
| below = | | below = |